|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 25-10-07 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 25-10-07 | MannKind Completes Acquisition of scPharmaceuticals | MT |
Chart calendar scPharmaceuticals Inc.
Upcoming events on scPharmaceuticals Inc.
No events available
Past events on scPharmaceuticals Inc.
| 2025-08-07 | Earnings release - Q2 2025 | |
| 2025-08-07 | Earnings presentation | 16:30 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 13,6 13,3 2.43% | 36,3 36,4 -0.21% |
|
EBITDA Million USD | Released Forecast Spread | -35,7 -37,8 5.49% | -55,4 -54,7 -1.23% | -44,9 -60,0 25.25% |
|
EBIT Million USD | Released Forecast Spread | -36,2 -35,4 -2.19% | -55,4 -54,4 -1.9% | -64,8 -63,5 -1.97% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -36,8 -37,7 2.17% | -54,8 -56,5 3% | -85,1 -84,0 -1.39% |
|
Net income Million USD | Released Forecast Spread | -36,8 -38,0 3.02% | -54,8 -57,3 4.36% | -85,1 -84,5 -0.79% |
|
EPS USD | Released Forecast Spread | -1,30 -1,35 3.42% | -1,42 -1,49 4.38% | -1,91 -1,92 0.69% |
| Announcement Date | 22/03/23 | 13/03/24 | 19/03/25 |
Quarterly results
| Fiscal Period | June | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,10 5,77 5.63% | 6,10 5,98 2.09% | 8,05 7,97 1.06% | 10,0 10,8 -7.17% | 12,2 12,2 -0.28% | 11,8 11,6 1.06% | 16,0 15,4 4.07% |
|
EBITDA Million USD | Released Forecast Spread | -15,2 -12,1 -26.02% | -15,8 -15,0 -5.64% | -14,4 -14,2 -1.43% | -18,1 -13,5 -34.33% | -14,3 -14,7 2.72% | -17,7 -14,7 -20.37% | -14,2 -13,5 -5.41% |
|
EBIT Million USD | Released Forecast Spread | -15,3 -14,1 -8.01% | -15,9 -15,6 -1.69% | -14,4 -14,7 2.11% | -18,1 -14,3 -26.64% | -16,3 -15,1 -8.29% | -17,8 -16,2 -9.71% | -14,3 -15,1 5.22% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,8 -15,1 8.4% | -14,1 -16,8 16.04% | -17,1 -15,9 -7.65% | -35,1 -15,0 -134.01% | -18,8 -17,7 -6.62% | -19,7 -17,1 -15.15% | -18,0 -15,7 -14.77% |
|
Net income Million USD | Released Forecast Spread | -13,8 -16,1 14.34% | -14,1 -17,4 18.93% | -17,1 -16,3 -4.98% | -35,1 -15,4 -127.69% | -18,8 -18,2 -3.66% | -19,7 -16,8 -17.59% | -18,0 -16,8 -7.39% |
|
EPS USD | Released Forecast Spread | -0,35 -0,42 16.33% | -0,36 -0,44 17.56% | -0,44 -0,42 -5.18% | -0,75 -0,30 -151.4% | -0,35 -0,38 7.49% | -0,37 -0,30 -24.16% | -0,34 -0,30 -14.09% |
| Announcement Date | 13/03/24 | 14/05/24 | 14/08/24 | 13/11/24 | 19/03/25 | 14/05/25 | 07/08/25 |
| 2026-07-26 |  | Earnings release - Q1 2027 | |
| 2026-07-26 | | Board of Directors Meeting | |
| 2026-07-27 | | Earnings release - Q2 2026 | 02:00 |
| 2026-07-27 | | Earnings presentation | 06:45 |
| 2026-07-27 | | Board of Directors Meeting | |
| 2026-07-27 | | Ex-dividend date - 0.39 CNY | 00:00 |
| 2026-07-27 | | Earnings release - Q2 2026 | P |
| 2026-07-27 | | Board of Directors Meeting | |
| 2026-07-27 | | Board of Directors Meeting | |
| 2026-07-27 | | Earnings presentation | 07:45 |
Past sector events for scPharmaceuticals Inc.
| 2026-07-24 | | Ex-dividend date - 0.43 USD | 00:00 |
| 2026-07-24 | | Earnings release - Q2 2026 | 03:00 |
| 2026-07-24 | | Earnings presentation | 04:00 |
| 2026-07-24 | | Ex-dividend date - 30 INR | 00:00 |
| 2026-07-24 | | Earnings presentation | 07:30 |
| 2026-07-24 | | Earnings release - Q1 2027 | |
| 2026-07-24 | | Ex-dividend date - 525 INR | 00:00 |
| 2026-07-24 | | Ex-dividend date for special dividend - 131 INR | 00:00 |
| 2026-07-24 | | Earnings presentation | 04:00 |
| 2026-07-24 | | Ex-dividend date - 34 INR | 00:00 |
- Stock Market
- Stocks
- SCPH Stock
- Calendar scPharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
